Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Poster: ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Mehdi Hamadani,Christopher Graham,Laura Liao, Kate Zhang,Hannah Strat,David Ungar,Weiyun Ai, Lei Chen,Carmelo Carlo-Stella

Clinical Lymphoma Myeloma and Leukemia（2022）

Cited 0|Views16
No score
Abstract
The observed survival plateau suggests Lonca-treated patients may include LTS. Multiple models fit the trial data well and align on survival projections. Additional follow-up may help refine the switch point of the hybrid model and confirm presence of LTS. ©2022 American Society of Clinical Oncology, Inc. Reused with permission. All rights reserved.
More
Translated text
Key words
ABCL,health services research,DLBCL,non-Hodgkin lymphoma,survival projection,loncastuximab tesirine,Phase II
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined